0 XP   0   0   0

DIVI'S LABORATORIES LTD.
Buy, Hold or Sell?

Should you buy, hold or sell DIVI'S LABORATORIES LTD.?

I guess you are interested in DIVI'S LABORATORIES LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse DIVI'S LABORATORIES LTD.

Let's start. I'm going to help you getting a better view of DIVI'S LABORATORIES LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is DIVI'S LABORATORIES LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how DIVI'S LABORATORIES LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value DIVI'S LABORATORIES LTD.. The closing price on 2023-01-27 was INR3,386 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
DIVI'S LABORATORIES LTD. Daily Candlestick Chart
DIVI'S LABORATORIES LTD. Daily Candlestick Chart
Summary









1. Valuation of DIVI'S LABORATORIES LTD.




Current price per share

INR3,385.55

2. Growth of DIVI'S LABORATORIES LTD.




Is DIVI'S LABORATORIES LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$1.4b$1.1b$299.3m20.7%

How much money is DIVI'S LABORATORIES LTD. making?

Current yearPrevious yearGrowGrow %
Making money$364.1m$244m$120m33.0%
Net Profit Margin33.6%28.9%--

How much money comes from the company's main activities?

3. Financial Health of DIVI'S LABORATORIES LTD.




Comparing to competitors in the industry




  Industry Rankings ()  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of DIVI'S LABORATORIES LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit DIVI'S LABORATORIES LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare DIVI'S LABORATORIES LTD. to the  industry mean.
  • A Net Profit Margin of 33.6% means that ₹0.34 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of DIVI'S LABORATORIES LTD.:

  • The MRQ is 33.6%. The company is making a huge profit. +2
  • The TTM is 33.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ33.6%TTM33.6%0.0%
TTM33.6%YOY28.9%+4.7%
TTM33.6%5Y29.2%+4.5%
5Y29.2%10Y29.2%0.0%
1.1.2. Return on Assets

Shows how efficient DIVI'S LABORATORIES LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare DIVI'S LABORATORIES LTD. to the  industry mean.
  • 22.1% Return on Assets means that DIVI'S LABORATORIES LTD. generated ₹0.22 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of DIVI'S LABORATORIES LTD.:

  • The MRQ is 22.1%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 22.1%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ22.1%TTM22.1%0.0%
TTM22.1%YOY18.4%+3.7%
TTM22.1%5Y18.4%+3.8%
5Y18.4%10Y18.4%0.0%
1.1.3. Return on Equity

Shows how efficient DIVI'S LABORATORIES LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare DIVI'S LABORATORIES LTD. to the  industry mean.
  • 25.2% Return on Equity means DIVI'S LABORATORIES LTD. generated ₹0.25 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of DIVI'S LABORATORIES LTD.:

  • The MRQ is 25.2%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 25.2%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ25.2%TTM25.2%0.0%
TTM25.2%YOY21.3%+3.9%
TTM25.2%5Y21.2%+4.0%
5Y21.2%10Y21.2%0.0%

1.2. Operating Efficiency of DIVI'S LABORATORIES LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient DIVI'S LABORATORIES LTD. is operating .

  • Measures how much profit DIVI'S LABORATORIES LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare DIVI'S LABORATORIES LTD. to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of DIVI'S LABORATORIES LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y16.6%-16.6%
5Y16.6%10Y16.6%0.0%
1.2.2. Operating Ratio

Measures how efficient DIVI'S LABORATORIES LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 0.93 means that the operating costs are ₹0.93 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of DIVI'S LABORATORIES LTD.:

  • The MRQ is 0.931. The company is less efficient in keeping operating costs low.
  • The TTM is 0.931. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.931TTM0.9310.000
TTM0.931YOY0.957-0.026
TTM0.9315Y1.000-0.069
5Y1.00010Y1.0000.000

1.3. Liquidity of DIVI'S LABORATORIES LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if DIVI'S LABORATORIES LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 6.99 means the company has ₹6.99 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of DIVI'S LABORATORIES LTD.:

  • The MRQ is 6.985. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.985. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.985TTM6.9850.000
TTM6.985YOY5.551+1.435
TTM6.9855Y5.769+1.216
5Y5.76910Y5.7690.000
1.3.2. Quick Ratio

Measures if DIVI'S LABORATORIES LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare DIVI'S LABORATORIES LTD. to the  industry mean.
  • A Quick Ratio of 3.30 means the company can pay off ₹3.30 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of DIVI'S LABORATORIES LTD.:

  • The MRQ is 3.305. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.305. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.305TTM3.3050.000
TTM3.305YOY1.556+1.749
TTM3.3055Y2.707+0.598
5Y2.70710Y2.7070.000

1.4. Solvency of DIVI'S LABORATORIES LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of DIVI'S LABORATORIES LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare DIVI'S LABORATORIES LTD. to industry mean.
  • A Debt to Asset Ratio of 0.12 means that DIVI'S LABORATORIES LTD. assets are financed with 12.3% credit (debt) and the remaining percentage (100% - 12.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of DIVI'S LABORATORIES LTD.:

  • The MRQ is 0.123. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.123. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.123TTM0.1230.000
TTM0.123YOY0.137-0.014
TTM0.1235Y0.135-0.012
5Y0.13510Y0.1350.000
1.4.2. Debt to Equity Ratio

Measures if DIVI'S LABORATORIES LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare DIVI'S LABORATORIES LTD. to the  industry mean.
  • A Debt to Equity ratio of 14.0% means that company has ₹0.14 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of DIVI'S LABORATORIES LTD.:

  • The MRQ is 0.140. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.140. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.140TTM0.1400.000
TTM0.140YOY0.159-0.019
TTM0.1405Y0.156-0.015
5Y0.15610Y0.1560.000

2. Market Valuation of DIVI'S LABORATORIES LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings DIVI'S LABORATORIES LTD. generates.

  • Above 15 is considered overpriced but always compare DIVI'S LABORATORIES LTD. to the  industry mean.
  • A PE ratio of 39.49 means the investor is paying ₹39.49 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of DIVI'S LABORATORIES LTD.:

  • The EOD is 30.359. Good. +1
  • The MRQ is 39.490. Good. +1
  • The TTM is 39.490. Good. +1
Trends
Current periodCompared to+/- 
EOD30.359MRQ39.490-9.131
MRQ39.490TTM39.4900.000
TTM39.490YOY48.565-9.075
TTM39.4905Y39.952-0.462
5Y39.95210Y39.9520.000
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of DIVI'S LABORATORIES LTD..

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of DIVI'S LABORATORIES LTD.:

  • The MRQ is 26.469. Seems overpriced? -1
  • The TTM is 26.469. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ26.469TTM26.4690.000
TTM26.469YOY33.690-7.221
TTM26.4695Y32.609-6.140
5Y32.60910Y32.6090.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of DIVI'S LABORATORIES LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 9.97 means the investor is paying ₹9.97 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of DIVI'S LABORATORIES LTD.:

  • The EOD is 7.663. Seems overpriced? -1
  • The MRQ is 9.968. Seems overpriced? -1
  • The TTM is 9.968. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD7.663MRQ9.968-2.305
MRQ9.968TTM9.9680.000
TTM9.968YOY10.368-0.400
TTM9.9685Y8.513+1.455
5Y8.51310Y8.5130.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of DIVI'S LABORATORIES LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--91.67191.6710%74.762+23%110.448-17%110.448-17%
Book Value Growth--1.2621.2620%1.272-1%1.195+6%1.195+6%
Book Value Per Share--441.792441.7920%350.121+26%332.336+33%332.336+33%
Book Value Per Share Growth--1.2621.2620%1.272-1%1.195+6%1.195+6%
Current Ratio--6.9856.9850%5.551+26%5.769+21%5.769+21%
Debt To Asset Ratio--0.1230.1230%0.137-10%0.135-9%0.135-9%
Debt To Equity Ratio--0.1400.1400%0.159-12%0.156-10%0.156-10%
Dividend Per Share--20.00020.0000%-+100%15.500+29%15.500+29%
Eps--111.518111.5180%74.747+49%72.269+54%72.269+54%
Eps Growth--1.4921.4920%1.442+3%1.317+13%1.317+13%
Free Cash Flow Per Share--45.15045.1500%39.053+16%23.443+93%23.443+93%
Free Cash Flow Per Share Growth--1.1561.1560%31.676-96%10.993-89%10.993-89%
Free Cash Flow To Equity Per Share--45.15045.1500%39.053+16%10.848+316%10.848+316%
Free Cash Flow To Equity Per Share Growth--1.1561.1560%2.979-61%-12.236+1158%-12.236+1158%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--0.3360.3360%0.289+16%0.292+15%0.292+15%
Operating Margin----0%-0%0.166-100%0.166-100%
Operating Ratio--0.9310.9310%0.957-3%1.000-7%1.000-7%
Pb Ratio7.663-30%9.9689.9680%10.368-4%8.513+17%8.513+17%
Pe Ratio30.359-30%39.49039.4900%48.565-19%39.952-1%39.952-1%
Peg Ratio--26.46926.4690%33.690-21%32.609-19%32.609-19%
Price Per Share3385.550-30%4403.8504403.8500%3630.050+21%2931.163+50%2931.163+50%
Price To Total Gains Ratio30.317-30%39.43639.4360%48.555-19%34.534+14%34.534+14%
Profit Growth--1.4921.4920%1.442+3%1.317+13%1.317+13%
Quick Ratio--3.3053.3050%1.556+112%2.707+22%2.707+22%
Return On Assets--0.2210.2210%0.184+20%0.184+20%0.184+20%
Return On Equity--0.2520.2520%0.213+18%0.212+19%0.212+19%
Revenue Growth--1.2831.2830%1.296-1%1.227+5%1.227+5%
Total Gains Per Share--111.671111.6710%74.762+49%125.948-11%125.948-11%
Total Gains Per Share Growth--1.4941.4940%1.651-10%1.104+35%1.104+35%
Usd Book Value--1442566140.0001442566140.0000%1143237030.000+26%1085163195.000+33%1085163195.000+33%
Usd Book Value Change Per Share--1.1281.1280%0.920+23%1.359-17%1.359-17%
Usd Book Value Per Share--5.4345.4340%4.306+26%4.088+33%4.088+33%
Usd Dividend Per Share--0.2460.2460%-+100%0.191+29%0.191+29%
Usd Eps--1.3721.3720%0.919+49%0.889+54%0.889+54%
Usd Free Cash Flow--147427800.000147427800.0000%127519020.000+16%76545975.000+93%76545975.000+93%
Usd Free Cash Flow Per Share--0.5550.5550%0.480+16%0.288+93%0.288+93%
Usd Free Cash Flow To Equity Per Share--0.5550.5550%0.480+16%0.133+316%0.133+316%
Usd Price Per Share41.642-30%54.16754.1670%44.650+21%36.053+50%36.053+50%
Usd Profit--364135350.000364135350.0000%244067670.000+49%235976115.000+54%235976115.000+54%
Usd Revenue--1082305290.0001082305290.0000%843575820.000+28%791891220.000+37%791891220.000+37%
Usd Total Gains Per Share--1.3741.3740%0.920+49%1.549-11%1.549-11%
 EOD+3 -2MRQTTM+0 -0YOY+32 -85Y+33 -810Y+33 -8

3.2. Fundamental Score

Let's check the fundamental score of DIVI'S LABORATORIES LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1530.359
Price to Book Ratio (EOD)Between0-17.663
Net Profit Margin (MRQ)Greater than00.336
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.305
Current Ratio (MRQ)Greater than16.985
Debt to Asset Ratio (MRQ)Less than10.123
Debt to Equity Ratio (MRQ)Less than10.140
Return on Equity (MRQ)Greater than0.150.252
Return on Assets (MRQ)Greater than0.050.221
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of DIVI'S LABORATORIES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose3,389.800
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets133,747,100
Total Liabilities16,465,300
Total Stockholder Equity117,281,800
 As reported
Total Liabilities 16,465,300
Total Stockholder Equity+ 117,281,800
Total Assets = 133,747,100

Assets

Total Assets133,747,100
Total Current Assets83,515,000
Long-term Assets83,515,000
Total Current Assets
Cash And Cash Equivalents 12,147,600
Short-term Investments 15,270,100
Net Receivables 24,238,800
Inventory 28,286,200
Other Current Assets 2,175,500
Total Current Assets  (as reported)83,515,000
Total Current Assets  (calculated)82,118,200
+/- 1,396,800
Long-term Assets
Intangible Assets 74,900
Long-term Assets Other 548,300
Long-term Assets  (as reported)50,232,100
Long-term Assets  (calculated)623,200
+/- 49,608,900

Liabilities & Shareholders' Equity

Total Current Liabilities11,955,500
Long-term Liabilities4,509,800
Total Stockholder Equity117,281,800
Total Current Liabilities
Accounts payable 7,957,000
Other Current Liabilities -102,400
Total Current Liabilities  (as reported)11,955,500
Total Current Liabilities  (calculated)7,854,600
+/- 4,100,900
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt36,900
Long-term Liabilities  (as reported)4,509,800
Long-term Liabilities  (calculated)36,900
+/- 4,472,900
Total Stockholder Equity
Retained Earnings 99,888,500
Total Stockholder Equity (as reported)117,281,800
Total Stockholder Equity (calculated)99,888,500
+/- 17,393,300
Other
Capital Stock530,900
Common Stock Shares Outstanding 265,469
Net Invested Capital 117,281,800
Net Working Capital 71,559,500



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
80,382,500
85,357,000
107,740,700
133,747,100
133,747,100107,740,70085,357,00080,382,50000
   > Total Current Assets 
40,105,100
45,351,200
46,500,500
46,798,300
61,747,100
83,515,000
83,515,00061,747,10046,798,30046,500,50045,351,20040,105,100
       Cash And Cash Equivalents 
0
0
130,000
431,500
20,303,200
12,147,600
12,147,60020,303,200431,500130,00000
       Short-term Investments 
0
0
13,983,400
9,823,600
546,400
15,270,100
15,270,100546,4009,823,60013,983,40000
       Net Receivables 
9,392,900
11,332,900
12,964,900
15,990,400
16,765,200
24,238,800
24,238,80016,765,20015,990,40012,964,90011,332,9009,392,900
       Inventory 
13,199,100
13,506,700
17,723,400
18,638,600
21,452,300
28,286,200
28,286,20021,452,30018,638,60017,723,40013,506,70013,199,100
       Other Current Assets 
940,500
1,305,100
1,606,900
1,744,500
1,531,900
2,175,500
2,175,5001,531,9001,744,5001,606,9001,305,100940,500
   > Long-term Assets 
0
0
33,882,000
38,558,700
45,993,600
50,232,100
50,232,10045,993,60038,558,70033,882,00000
       Property Plant Equipment 
19,995,000
21,094,000
25,756,300
36,979,400
0
0
0036,979,40025,756,30021,094,00019,995,000
       Intangible Assets 
0
0
40,500
36,000
49,500
74,900
74,90049,50036,00040,50000
       Long-term Assets Other 
0
0
0
100
562,500
548,300
548,300562,500100000
> Total Liabilities 
0
0
10,811,000
12,257,800
14,794,600
16,465,300
16,465,30014,794,60012,257,80010,811,00000
   > Total Current Liabilities 
6,594,500
6,534,200
8,467,500
9,268,300
11,124,600
11,955,500
11,955,50011,124,6009,268,3008,467,5006,534,2006,594,500
       Short Long Term Debt 
0
0
1,056,000
336,300
3,500
0
03,500336,3001,056,00000
       Accounts payable 
4,458,000
4,112,100
4,922,600
5,907,200
7,632,000
7,957,000
7,957,0007,632,0005,907,2004,922,6004,112,1004,458,000
       Other Current Liabilities 
566,700
645,600
743,200
1,128,200
-47,200
-102,400
-102,400-47,2001,128,200743,200645,600566,700
   > Long-term Liabilities 
0
0
2,343,500
2,989,500
3,670,000
4,509,800
4,509,8003,670,0002,989,5002,343,50000
       Capital Lease Obligations Min Short Term Debt
0
0
0
52,200
44,800
36,900
36,90044,80052,200000
> Total Stockholder Equity
0
0
69,571,500
73,099,200
92,946,100
117,281,800
117,281,80092,946,10073,099,20069,571,50000
   Common Stock
530,900
530,900
530,900
530,900
0
0
00530,900530,900530,900530,900
   Retained Earnings Total Equity000000
   Accumulated Other Comprehensive Income 000000
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
0
92,300
78,300
133,900
0
0
00133,90078,30092,3000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue87,992,300
Cost of Revenue-29,671,400
Gross Profit58,320,90058,320,900
 
Operating Income (+$)
Gross Profit58,320,900
Operating Expense-52,254,600
Operating Income35,737,7006,066,300
 
Operating Expense (+$)
Research Development202,900
Selling General Administrative2,356,000
Selling And Marketing Expenses-
Operating Expense52,254,6002,558,900
 
Net Interest Income (+$)
Interest Income689,600
Interest Expense-3,700
Net Interest Income669,600685,900
 
Pretax Income (+$)
Operating Income35,737,700
Net Interest Income669,600
Other Non-Operating Income Expenses-
Income Before Tax (EBT)36,835,00035,737,700
EBIT - interestExpense = -3,700
29,604,500
29,608,200
Interest Expense3,700
Earnings Before Interest and Taxes (ebit)-36,838,700
Earnings Before Interest and Taxes (ebitda)39,953,800
 
After tax Income (+$)
Income Before Tax36,835,000
Tax Provision-7,230,500
Net Income From Continuing Ops29,604,50029,604,500
Net Income29,604,500
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--669,600
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
NGU24-NYM.COMM
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGU24-NYM.COMM.

NGU24-NYM.COMM Daily Candlestick Chart
NGM24-NYM.COMM
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGM24-NYM.COMM.

NGM24-NYM.COMM Daily Candlestick Chart
NGQ24-NYM.COMM
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGQ24-NYM.COMM.

NGQ24-NYM.COMM Daily Candlestick Chart
ISKJ.MCX
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ISKJ.MCX.

ISKJ.MCX Daily Candlestick Chart
CHKZ.MCX
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHKZ.MCX.

CHKZ.MCX Daily Candlestick Chart
VSYD.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VSYD.MCX.

VSYD.MCX Daily Candlestick Chart
VRSB.MCX
2 hours ago

I found you a Golden Cross on the daily chart of VRSB.MCX.

VRSB.MCX Daily Candlestick Chart
TBRU.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBRU.MCX.

TBRU.MCX Daily Candlestick Chart
SNGSP.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SNGSP.MCX.

SNGSP.MCX Daily Candlestick Chart
RBCM.MCX
2 hours ago

I found you a Golden Cross on the daily chart of RBCM.MCX.

RBCM.MCX Daily Candlestick Chart
OKEY.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OKEY.MCX.

OKEY.MCX Daily Candlestick Chart
MTLR.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MTLR.MCX.

MTLR.MCX Daily Candlestick Chart
MRKZ.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MRKZ.MCX.

MRKZ.MCX Daily Candlestick Chart
KRKN.MCX
2 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of KRKN.MCX.

KRKN.MCX Daily Candlestick Chart
JNOS.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JNOS.MCX.

JNOS.MCX Daily Candlestick Chart
BLNG.MCX
2 hours ago

I found you a Golden Cross on the daily chart of BLNG.MCX.

BLNG.MCX Daily Candlestick Chart
ASSB.MCX
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ASSB.MCX.

ASSB.MCX Daily Candlestick Chart
CSYZ.MU
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CSYZ.MU.

CSYZ.MU Daily Candlestick Chart
MOH.MU
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MOH.MU.

MOH.MU Daily Candlestick Chart
TBK.V
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBK.V.

TBK.V Daily Candlestick Chart
UMDK.F
2 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of UMDK.F.

UMDK.F Daily Candlestick Chart
RY4C.BE
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RY4C.BE.

RY4C.BE Daily Candlestick Chart
PLY.BE
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PLY.BE.

PLY.BE Daily Candlestick Chart
PDL.LSE
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PDL.LSE.

PDL.LSE Daily Candlestick Chart
27F0.MU
2 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of 27F0.MU.

27F0.MU Daily Candlestick Chart